1-20 of 70
Hua Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO2-03-05: Neoadjuvant anthracycline followed by Toripalimab combined with nab-paclitaxel in patients with stage IIA-IIIC triple negative breast cancer (NeoTENNIS): efficacy and safety results of a phase II study

Min He, Linxiaoxi Ma, Shuang Hao, Benlong Yang, Bingqiu Xiu, Ya-Yun Chi, Ruo-Hong Shui, Zhong-Hua Wang, Zhi-Ming Shao, Jiong Wu
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO2-03-05.
https://doi.org/10.1158/1538-7445.SABCS23-PO2-03-05
Published: 02 May 2024
View article titled, Abstract PO2-03-05: Neoadjuvant anthracycline followed by Toripalimab combined with nab-paclitaxel in patients with stage IIA-IIIC triple negative breast cancer (NeoTENNIS): efficacy and safety results of a phase II study
Journal Articles

Abstract PO1-14-07: Programme of mast cell subsets to potentiate breast cancer immunotherapy: from bed to bench to bed (the phase 2 platform RENAISSANCE trial)

Song-Yang Wu, Xi Jin, Yin Liu, Wen-Jia Zuo, Li Chen, Xiyu Liu, Lei Fan, Zhong-Hua Wang, Yan-Fei Liu, Yi-Zhou Jiang, Zhi-Ming Shao
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO1-14-07.
https://doi.org/10.1158/1538-7445.SABCS23-PO1-14-07
Published: 02 May 2024
View article titled, Abstract PO1-14-07: Programme of mast cell subsets to potentiate breast cancer immunotherapy: from bed to bench to bed (the phase 2 platform RENAISSANCE trial)
Journal Articles

Abstract PO1-15-08: Genomic characterization of triple-negative breast cancer metastases reveals PKD1 as a novel biomarker for immunotherapy

Xiu-Zhi Zhu, Yi-Fan Zhou, Yun-Yi Wang, Xiao-Hong Ding, Xi Jin, Zhi-Ming Shao, Yi-Zhou Jiang, Zhong-Hua Wang
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO1-15-08.
https://doi.org/10.1158/1538-7445.SABCS23-PO1-15-08
Published: 02 May 2024
View article titled, Abstract PO1-15-08: Genomic characterization of triple-negative breast cancer metastases reveals PKD1 as a novel biomarker for immunotherapy
Journal Articles

Abstract PO1-15-07: Subtyping-directed precision treatment refines traditional one-size-fits-all therapy in HR+/HER2- breast cancer: a sub-study of the MULAN umbrella trial

Xiu-Zhi Zhu, Xi Jin, Hu-Yun-Long Zhang, Xiyu Liu, Yi-Fan Zhou, Yi-Yu Chen, Tong Fu, Ming-Liang Jin, Ya-Xin Zhao, Yi-Fan Xie, Ruo-Xi Wang, Zhong-Hua Wang, Lei Fan, Yi-Zhou Jiang, Zhi-Ming Shao
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO1-15-07.
https://doi.org/10.1158/1538-7445.SABCS23-PO1-15-07
Published: 02 May 2024
View article titled, Abstract PO1-15-07: Subtyping-directed precision treatment refines traditional one-size-fits-all therapy in HR+/HER2- breast cancer: a sub-study of the MULAN umbrella trial
Journal Articles

Abstract CT152: A multicenter Phase II study of savolitinib in patients with MET-amplified gastroesophogeal junction adenocarcinomas or gastric cancer

Zhi Peng, Hua Wang, Baorui Liu, Huiting Xu, Zhenyang Liu, Tianshu Liu, Jun Zhang, Yuxian Bai, Ying Yuan, Tao Wu, Feng Ye, Qinghua Pan, Jufeng Wang, Enxiao Li, Diansheng Zhong, Yueyin Pan, Yanru Qin, Yan Yang, Yusheng Wang, Aiping Zhou, Yongshun Chen, Dianbao Zhang, Hongli Liu, Xiujuan Qu, Shubin Wang, Ning Liu, Jinsheng Wu, Wei Li, Kejun Nan, Hongming Pan, Jianming Xu, Chunmei Bai, Heling Liu, Jia Wei, Runzhi Chen, Rongrong Li, Wei Li, Jinghong Zhou, Hongyan Yin, Qian Xu, Songhua Fan, Yongxin Ren, Weiguo Su, Lin Shen
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT152.
https://doi.org/10.1158/1538-7445.AM2023-CT152
Published: 14 April 2023
View article titled, Abstract CT152: A multicenter Phase II study of savolitinib in patients with MET-amplified gastroesophogeal junction adenocarcinomas or gastric cancer
Journal Articles

Abstract OT3-27-01: Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: a multicenter, phase 2, umbrella, FUTURE trial

Zhi-Ming Shao, Zhong-Hua Wang, Yi-Zhou Jiang, Yin Liu, Xiu-Zhi Zhu, Yi Xiao, Song-Yang Wu, Wen-Jia Zuo, Qiang Yu, A-Yong Cao, Jun-Jie Li, Ke-Da Yu, Guang-Yu Liu, Jiong Wu, Tao Sun, Jiuwei Cui, Zheng Lv, Hui-Ping Li, Xiao-Yu Zhu
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT3-27-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT3-27-01
Published: 01 March 2023
View article titled, Abstract OT3-27-01: Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: a multicenter, phase 2, umbrella, FUTURE trial
Journal Articles

Abstract P1-11-20: Trastuzumab (HLX02) plus Pertuzumab as Dual-target Neoadjuvant Therapy for HER2-positive Breast Cancer: A Real-World Study

Yin Liu, Wen-Jia Zuo, Ruo-Xi Wang, Zhong-Hua Wang, Zhi-Ming Shao
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P1-11-20.
https://doi.org/10.1158/1538-7445.SABCS22-P1-11-20
Published: 01 March 2023
View article titled, Abstract P1-11-20: Trastuzumab (HLX02) plus Pertuzumab as Dual-target Neoadjuvant Therapy for HER2-positive Breast Cancer: A Real-World Study
Journal Articles

Abstract OT2-18-01: Nab-paclitaxel followed by dose-dense epirubicin/cyclophosphamide in neoadjuvant chemotherapy for triple-negative breast cancer: an open-label, single-arm phase II study

Yin Liu, Lei Fan, Zhi-Ming Shao, Zhong-Hua Wang
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT2-18-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT2-18-01
Published: 01 March 2023
View article titled, Abstract OT2-18-01: Nab-paclitaxel followed by dose-dense epirubicin/cyclophosphamide in neoadjuvant chemotherapy for triple-negative breast cancer: an open-label, single-arm phase II study
Journal Articles

Abstract LB568: Protein phosphatase 4 deficiency protects mice against cerulein-induced acute pancreatitis

Hua Wang, Reza Abbasgholizadeh, Rohan Moniruzzaman, Baoan Ji, Anirban Maitra, Huamin Wang
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB568.
https://doi.org/10.1158/1538-7445.AM2022-LB568
Published: 15 June 2022
View article titled, Abstract LB568: Protein phosphatase 4 deficiency protects mice against cerulein-induced acute pancreatitis
Journal Articles

Abstract 5092: Predictive biomarkers for the efficacy of PD-1 inhibitors plus chemotherapy for gastric/gastroesophageal junction cancer in first-line setting

Yu-Ting Sun, Shi-Xun Lu, Ming-Yu Lai, Xia Yang, Wen-Long Guan, Li-Qiong Yang, Yu-Hong Li, Feng-Hua Wang, Rui-Hua Xu, Miao-Zhen Qiu
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5092.
https://doi.org/10.1158/1538-7445.AM2022-5092
Published: 15 June 2022
View article titled, Abstract 5092: Predictive biomarkers for the efficacy of PD-1 inhibitors plus chemotherapy for gastric/gastroesophageal junction cancer in first-line setting
Journal Articles

Abstract P2-13-11: Response to anti-HER2 neoadjuvant chemotherapy in invasive breast cancers with different HER2 FISH-positive patterns

Hong Lv, Qian-Ming Bai, Yin Liu, Zhong-Hua Wang, Ruo-Hong Shui, Hong-Fen Lu, Xiao-Li Xu, Bao-Hua Yu, Xiao-Yu Tu, Rui Bi, Yu-Fan Cheng, Xiao-Yan Zhou, Zhi-Min Shao, Wen-Tao Yang
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-13-11.
https://doi.org/10.1158/1538-7445.SABCS21-P2-13-11
Published: 15 February 2022
View article titled, Abstract P2-13-11: Response to anti-HER2 neoadjuvant chemotherapy in invasive breast cancers with different HER2 FISH-positive patterns
Journal Articles

Abstract 4577: ONM-500: A STING-activating therapeutic nanovaccine platform for cancer immunotherapy

Jason Miller, Min Luo, Hua Wang, Zhaohui Wang, Xinliang Ding, Ashley Campbell, Jonathan Almazan, Stephen Gutowski, Zhijian Chen, Jinming Gao, Tian Zhao
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4577.
https://doi.org/10.1158/1538-7445.AM2020-4577
Published: 15 August 2020
View article titled, Abstract 4577: ONM-500: A STING-activating therapeutic nanovaccine platform for cancer immunotherapy
Journal Articles

Abstract 4711: Novel mechanism involved in the regulation ofoncogenic Axl receptor tyrosine kinase in cancer

Hua Wang, Xianzhou Song, Hironari Akasaka, Reza Abbasgholizadeh, Ji-Hyun Shin, Craig D. Logsdon, Anirban Maitra, Andrew J. Bean, Huamin Wang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4711.
https://doi.org/10.1158/1538-7445.AM2020-4711
Published: 15 August 2020
View article titled, Abstract 4711: Novel mechanism involved in the regulation ofoncogenic Axl receptor tyrosine kinase in cancer
Journal Articles

Abstract CT406: Patients with cancer appear more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak

Meng-Yuan Dai, Dian-bo Liu, Miao Liu, Fu-Xiang Zhou, Gui-Ling Li, Zhen Chen, Zhi-An Zhang, Hua-You Md, Meng Wu, Qi-Chao Zheng, Yong Xiong, Hui-Hua Xiong, Chun Wang, Chang-Chun Chen, Fei Xiong, Yan Zhang, Ya-Qin Peng, Si-Ping Ge, Bo Zhen, Ting-Ting Yu, Ling Wang, Hua Wang, Yu Liu, Ye-Shan Chen, Jun-Hua Mei, Xiao-Jia Gao, Zhu-Yan Li, Li-Juan Gan, Can He, Zhen Li, Yu-Ying Shi, Yu-Wen Qi, Jing Yang, Daniel G. Tenen, Li Chai, Lorelei Ann Mucci, Mauricio Santillana, Hongbing Cai
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT406.
https://doi.org/10.1158/1538-7445.AM2020-CT406
Published: 15 August 2020
View article titled, Abstract CT406: Patients with cancer appear more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak
Journal Articles

Abstract P4-09-01: Clinical sequencing characterizes the genomic landscape and actionable mutations of Chinese breast cancer

Guan-Tian Lang, Jin-Xiu Shi, Yi-Zhou Jiang, Xiao-Guang Li, Yu-Chen Pei, Fang-Lin Zhang, Chen-Hui Zhang, Ding Ma, Yi Xiao, Ke-Da Yu, Peng-Chen Hu, Ming-Liang Jin, Hai Wang, Yun-Song Yang, Xuan Luo, Qi Hong, Feng Qiao, Wei-Li Sun, Meng-Zhu Xue, Shi-Ping Li, A-Yong Cao, Zhong-Hua Wang, Jia-Xin Zhang, Gen-Hong Di, Peng Wang, Da-Qiang Li, Xin Hu, Wei Huang, Zhi-Ming Shao
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-09-01.
https://doi.org/10.1158/1538-7445.SABCS19-P4-09-01
Published: 15 February 2020
View article titled, Abstract P4-09-01: Clinical sequencing characterizes the genomic landscape and actionable mutations of Chinese breast cancer
Journal Articles

Abstract 4324: Prognostic potential of DNA methylation levels of EPDR1 and CHST10 in colorectal cancer

Chun-Ho Chu, Shih-Ching Chang, Hsiu-Hua Wang, Shung-Haur Yang, Te-Chang Lee, Kuo-Chu Lai
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4324.
https://doi.org/10.1158/1538-7445.AM2019-4324
Published: 01 July 2019
View article titled, Abstract 4324: Prognostic potential of DNA methylation levels of <em>EPDR1</em> and <em>CHST10</em> in colorectal cancer
Journal Articles

A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma

Shi-Lu Chen, Chris Zhiyi Zhang, Li-Li Liu, Shi-Xun Lu, Ying-Hua Pan, Chun-Hua Wang, Yang-Fan He, Cen-Shan Lin, Xia Yang, Dan Xie, Jing-Ping Yun
Journal: Cancer Research
Cancer Res (2019) 79 (3): 534–545.
https://doi.org/10.1158/0008-5472.CAN-18-2357
Published: 01 February 2019
View article titled, A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma
Open the PDF for A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma in another window
Journal Articles

Abstract 100: Interleukin 1 receptor type II upregulates MMP1 expression and increases motility of keratinocytes cells

Hsiu-Hua Wang, Te-Chang Lee
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 100.
https://doi.org/10.1158/1538-7445.AM2018-100
Published: 01 July 2018
View article titled, Abstract 100: Interleukin 1 receptor type II upregulates MMP1 expression and increases motility of keratinocytes cells
Journal Articles

Abstract 2566: A TCL1-specific T-cell receptor redirects T cells against B-cell lymphomas and non-hematological tumors

Jinsheng Weng, Kelsey E. Moriarty, Yong Pan, Flavio Egidio Baio, Hua Wang, Hiroki Torikai, Sourindra N. Maiti, Fuliang Chu, Xiaoyun Cheng, Swathi Karri, Deepshika Medapalli, Laurence J. N. Cooper, Sattva S. Neelapu
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2566.
https://doi.org/10.1158/1538-7445.AM2018-2566
Published: 01 July 2018
View article titled, Abstract 2566: A TCL1-specific T-cell receptor redirects T cells against B-cell lymphomas and non-hematological tumors
Journal Articles

Abstract 3763: IDO vaccine enhances antigen-specific anti-tumor effects by reducing IDO-expressing antigen presenting cells and MDSCs

Rahul Nandre, Vivek Verma, Pankaj Gaur, Pooja Vir, Hua Wang, Baolin Kang, Ayako Wakatsuki Pedersen, Mai-Britt Zocca, Mads Hald Andersen, Seema Gupta, Samir Khleif
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3763.
https://doi.org/10.1158/1538-7445.AM2018-3763
Published: 01 July 2018
View article titled, Abstract 3763: IDO vaccine enhances antigen-specific anti-tumor effects by reducing IDO-expressing antigen presenting cells and MDSCs